The treatment of diabetes relies heavily on careful glucose monitoring as an important component. Nevertheless, further information on the context is required in order to completely comprehend and interpret glucose levels in a meaningful manner. Continuous glucose monitoring (CGM), automated analysis of new glucose variables, and visualisation of CGM data via the ambulatory glucose profile have all contributed to significant advancements in precise glucose monitoring over the past five years. This made significant improvements in glucose monitoring. There are considerable challenges to its adoption, such as the fact that it is inconvenient and does not give immediate and frequent feedback. However, intermittent self-monitored blood glucose (SMBG) can offer extra information that may be used to make choices about therapy. Systems that indicate greater results compared to standard SMBG alone include those that give instant feedback to patients as well as decision support tools for both patients and physicians.
Rajasekar et al. (Thu,) studied this question.